April 21, 2024 Comments Off on New tentative approval for Xiamen Lp drug topiramate Posted in: Tentative Approval [](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
April 21, 2024 Comments Off on New patent expiration for Nalpropion drug CONTRAVE Posted in: Uncategorized
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from one supplier. There are twenty patents protecting…
Source
